Get the Stockscreener App
27.13
8.59%
-2.56
Instil Bio Inc stock is traded at $27.13, with a volume of 80,242.
It is down -8.59% in the last 24 hours and up +18.15% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$29.69
Open:
$29.77
24h Volume:
80,242
Relative Volume:
0.25
Market Cap:
$177.94M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-2.3819
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-4.57%
1M Performance:
+18.15%
6M Performance:
+3.15%
1Y Performance:
+123.03%
1-Day Range:
$27.13
$29.77
1-Week Range:
$27.13
$32.76
52-Week Range:
$9.85
$92.00
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
27.13 | 207.88M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.96 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.35 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.89 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
593.35 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
303.67 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
How to interpret RSI for Instil Bio Inc. stockStable Profit Zone and Loss Control Analysis - Newser
What high frequency data says about Instil Bio Inc.Trading Volume Anomaly Summary and Insight - Newser
What makes Instil Bio Inc. stock price move sharplyStrong Buy Signal Summary with Entry Zone - Newser
Will Instil Bio Inc. stock benefit from interest rate changesStrong Buy Opportunity with Volume Support - Newser
How volatile is Instil Bio Inc. stock compared to the marketDouble-digit growth - jammulinksnews.com
How to interpret RSI for Instil Bio Inc. stock High Return Idea With Technical Filter - Newser
Candlestick signals on Instil Bio Inc. stock today Free Wealth Building Stock Market Ideas - Newser
What are Instil Bio Inc. company’s key revenue driversUnlock daily market insights for better trades - jammulinksnews.com
How does Instil Bio Inc. compare to its industry peersAchieve rapid financial growth with expert help - jammulinksnews.com
What is the risk reward ratio of investing in Instil Bio Inc. stockHigh-margin investment plays - jammulinksnews.com
Instil Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWatchlist Winner Update - metal.it
Is Instil Bio Inc. stock overvalued or undervaluedFree Stock Movement Tracking - jammulinksnews.com
How strong is Instil Bio Inc. company’s balance sheetUnlock daily market insights for better decisions - jammulinksnews.com
Should I hold or sell Instil Bio Inc. stock in 2025Get timely market insights for better trades - jammulinksnews.com
Instil Bio Inc. Stock Support and Resistance Levels You Should KnowFree Market Sentiment Analysis - Newser
Is Instil Bio Inc. a good long term investmentUnrivaled growth potential - PrintWeekIndia
Should I buy Instil Bio Inc. stock before earningsBreakthrough financial growth - jammulinksnews.com
Will Instil Bio Inc. stock benefit from AI tech trendsAccelerated capital growth - jammulinksnews.com
What analysts say about Instil Bio Inc. stockFree Investment Community - PrintWeekIndia
Instil Bio Inc. Stock Analysis and ForecastOver 200% growth - Autocar Professional
Can Instil Bio Inc. stock recover from recent declineRecord-breaking capital gains - jammulinksnews.com
What drives Instil Bio Inc. stock priceExceptional portfolio growth - jammulinksnews.com
(TIL) Proactive Strategies - news.stocktradersdaily.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.22%
3.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):